Exela Pharma Sciences
PrivateLast Round
Grant
Dec 22, 2022
Total Funding Raised
$87.83M
Company Overview
Exela Pharma Sciences is a pharmaceutical company that develops, manufactures, and markets proprietary and generic sterile injectable products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exela Pharma Sciences Comparables
Compare Exela Pharma Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SCA Pharma | 85% | |
| Sagent Pharmaceuticals | 84% | |
| Nephron Pharmaceuticals Corporation | 81% |
Exela Pharma Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 22, 2022 | ||||
| Grant | May 5, 2022 | ||||
| Debt | Oct 1, 2021 | ||||
| Debt | Jul 24, 2013 | ||||
| Grant | Jan 3, 2013 | ||||
Series A | Jul 1, 2008 |
Exela Pharma Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Administration for Strategic Preparedness and Response | Grant |
| Presidio Partners | Series A |
| Trinity Capital | Debt |
| U.S. Department of Agriculture | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 17, 2025
Company requests new trial for patent infringement allegations.
- Dec 22, 2022
$2M grant from the Administration for Strategic Preparedness and Response.
Exela Pharma Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exela Pharma Sciences's valuation, stock price, and market status.
Is Exela Pharma Sciences a public or private company?
Exela Pharma Sciences is a private company.
What is the current stock price of Exela Pharma Sciences?
Exela Pharma Sciences is a private company, so its shares have no public market price. Caplight tracks Exela Pharma Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exela Pharma Sciences worth (valuation)?
Valuation information for Exela Pharma Sciences is not publicly available.
Can I buy Exela Pharma Sciences stock?
Exela Pharma Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exela Pharma Sciences's last funding round?
Exela Pharma Sciences's most recent funding round was Grant on December 22, 2022.
Who are the main investors in Exela Pharma Sciences?
Key investors in Exela Pharma Sciences include Presidio Partners, Trinity Capital.
Will Exela Pharma Sciences IPO soon?
No public IPO plans have been announced for Exela Pharma Sciences.
How can I track Exela Pharma Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Exela Pharma Sciences's shares on secondary markets.